Microbial metabolites for cancer immunotherapy: Current evidence and future directions
Seminars in Cancer Biology · 2025-12 · 117 · 89-110
DOI: 10.1016/j.semcancer.2025.10.005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2025-12. Verfasst von Xin-Xin Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Lab…. Hauptthemen laut MEDLINE: Neoplasms, Immunotherapy, Microbiota. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 309 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan Univer…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, X. X., Liang, J. J., Duan, X., & Chen, G. (2025). Microbial metabolites for cancer immunotherapy: Current evidence and future directions. Seminars in Cancer Biology, 117, 89-110. https://doi.org/10.1016/j.semcancer.2025.10.005
Vancouver
Wang XX, Liang JJ, Duan X, Chen G. Microbial metabolites for cancer immunotherapy: Current evidence and future directions. Seminars in Cancer Biology. 2025;117:89-110. doi:10.1016/j.semcancer.2025.10.005
BibTeX
@article{Wang2025,
author = {Wang, Xin-Xin and Liang, Jia-Jie and Duan, Xu and Chen, Gang},
title = {Microbial metabolites for cancer immunotherapy: Current evidence and future directions},
journal = {Seminars in Cancer Biology},
year = {2025},
volume = {117},
pages = {89--110},
doi = {10.1016/j.semcancer.2025.10.005}
}
EUVIMED